Although the exact mechanism of KOR-mediated GSK3β activation remains unclear at this time, we propose that the stimulation of KOR may activate GSK3β through inhibition of the cAMP/PKA pathway and/or activation of the JNK pathway in NSCLC, resulting in the prevention of cancer. Here, OPRK1 is linked to non-small cell lung carcinoma.